BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 27896453)

  • 1. Management of phosphorus load in CKD patients.
    Taketani Y; Koiwa F; Yokoyama K
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):27-36. PubMed ID: 27896453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate, Microbiota and CKD.
    Favero C; Carriazo S; Cuarental L; Fernandez-Prado R; Gomá-Garcés E; Perez-Gomez MV; Ortiz A; Fernandez-Fernandez B; Sanchez-Niño MD
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Komaba H; Tanaka M; Fukagawa M
    Intern Med; 2008; 47(11):989-94. PubMed ID: 18520108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ; González EA
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.
    Li J; Wang L; Han M; Xiong Y; Liao R; Li Y; Sun S; Maharjan A; Su B
    Nutr Diabetes; 2019 Apr; 9(1):14. PubMed ID: 30944300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of controlling phosphorus in chronic kidney disease.
    Cannata-Andía JB; Martin KJ
    Nephrol Dial Transplant; 2016 Apr; 31(4):541-7. PubMed ID: 25770169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.
    Stremke ER; Biruete A; Hill Gallant KM
    Curr Osteoporos Rep; 2020 Jun; 18(3):247-253. PubMed ID: 32240477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease.
    Zhou C; Wang F; Wang JW; Zhang LX; Zhao MH
    Chin Med J (Engl); 2016 Oct; 129(19):2275-80. PubMed ID: 27647184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder.
    Egstrand S; Olgaard K; Lewin E
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):367-377. PubMed ID: 32452917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic kidney disease and nutrition].
    Yoshida T; Kumagai H
    Clin Calcium; 2016 Mar; 26(3):369-74. PubMed ID: 26923973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women and CKD-mineral and bone disorder.
    Ho LT; Sprague SM
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):423-6. PubMed ID: 23978548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone and Nutrition. Nutrition care of renal osteodystrophy].
    Tanaka S; Ito M
    Clin Calcium; 2015 Jul; 25(7):1057-62. PubMed ID: 26119320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Phosphorus as a Marker of Mineral Metabolism and Progression of Diabetic Kidney Disease.
    Winiarska A; Filipska I; Knysak M; Stompór T
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33673618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.